TECTONIC THERAPEUTIC, INC.
Profile
Company Names
TECTONIC THERAPEUTIC, INC.
AVROBIO, INC.
Addresses
490 ARSENAL WAY, SUITE 210, WATERTOWN, MA 02472
ONE KENDALL SQUARE, BLDG. 300, SUITE 201, CAMBRIDGE, MA 02139
400 TECHNOLOGY SQ., 10TH FLR., CAMBRIDGE, MA 02139
Phone Numbers
(339) 666-3320
617-914-8420
857-201-2754
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$253,027,620.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-02-05
$185,027,642.00
$185,027,642.00
$0.00
Equity
2
2018-01-19
$60,499,978.00
$60,999,978.00
$500,000.00
Equity
1
2016-07-21
$7,500,000.00
$25,000,000.00
$17,500,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRUCE
BOOTH
DIRECTOR
MIRAGEN THERAPEUTICS INC
| AVILA THERAPEUTICS INC
| ZAFGEN, INC.
| NIMBUS DISCOVERY, LLC
| ON-Q-ITY, INC.
| NUMERATE INC
| UNUM THERAPEUTICS, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| AVROBIO, INC.
| MAGENTA THERAPEUTICS, INC.
| ATLAS VENTURE FUND XI, L.P.
| RODIN THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| VIGIL NEUROSCIENCE, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| MATCHPOINT THERAPEUTICS INC.
| ATLAS VENTURE FUND XIV, L.P.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
IAN
CLARK
DIRECTOR
PHILLIP
B.
DONENBERG
DIRECTOR
CHRISTOPHER
MASON
EXECUTIVE OFFICER
TERRANCE
MCGUIRE
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, INC.
| ARSANIS, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, LLC
| 480 BIOMEDICAL, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ICELANDIC PROVISIONS, INC.
| SEER BIOSCIENCES, INC.
| CYCLERION THERAPEUTICS, INC.
| ANKYRA THERAPEUTICS, INC.
| ADAGIO THERAPEUTICS, INC.
| FARADAY PHARMACEUTICALS, INC.
| TECTONIC THERAPEUTIC, INC.
SCOTT
REQUADT
DIRECTOR
JOSHUA
RESNICK
DIRECTOR
JERICHO CAPITAL PARTNERS, L.P.
| COAXIA INC
| JERICHO CAPITAL INTERNATIONAL LTD.
| LIVESTREAM, LLC
| JERICHO CAPITAL PARTNERS L.P.
| SUGARFINA, LLC
| RANA THERAPEUTICS, LLC
| MIRAGEN THERAPEUTICS, INC.
| JERICHO CAPITAL SPECIAL OPPORTUNITIES LTD
| AVROBIO, INC.
| SUGARFINA, INC.
| RIBOMETRIX, INC.
| NAYAN THERAPEUTICS, INC.
| JERICHO ASIA OPPORTUNITIES LTD.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| VOR BIOPHARMA INC.
| AVILAR THERAPEUTICS, INC.
| PEPGEN INC.
| TRIANA BIOMEDICINES, INC.
| ALIADA THERAPEUTICS, INC.
| OPENSKY VENTURES FUND I, LP
TIMOTHY
SPRINGER
DIRECTOR
STEFAN
VITOROVIC
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-02-05

